Alan Celik et al. 2025. Impact of age and comorbidities on real-world outcomes in advanced breast cancer patients treated with palbociclib in first line: a nation-wide Danish retrospective study. Acta Oncologica. 64, (Jun. 2025), 778–783. DOI:https://doi.org/10.2340/1651-226X.2025.43226.